Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kutok Jeffery Insider Profile
4 Followers
Kutok Jeffery, CSO at Infinity Pharma, holds 27.41K shares in Epizyme (Ticker: EPZM), holds 88.12K shares in Infinity Pharma (Ticker: INFI).
Kutok Jeffery has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kutok Jeffery holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kutok Jeffery
Kutok Jeffery's Trading History
Infinity Pharma
Jan 13, 2020
CSO
Uninformative Buy
―
$176.24K
Epizyme
Apr 03, 2020
Chief Scientific Officer
Uninformative Buy
―
$332.51K
List of latest transactions for each holding click on a transaction to see Kutok Jeffery's performance on stock
You May Also Like
Kutok Jeffery insider profile FAQ
What is the percentage of profitable transactions made by Kutok Jeffery?
The percentage of profitable transactions made by Kutok Jeffery is ―.
What is the average return per transaction made by Kutok Jeffery?
The average return per transaction made by Kutok Jeffery is ―.
What stocks does Kutok Jeffery hold?
Kutok Jeffery holds: INFI, EPZM stocks.
What was Kutok Jeffery’s latest transaction?
Kutok Jeffery latest transaction was an Uninformative Buy of ―.
What was Kutok Jeffery's most profitable transaction?
Kutok Jeffery’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kutok Jeffery's role in Infinity Pharma?
Kutok Jeffery's role in Infinity Pharma is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.